| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.32 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |